Know How Tresiba Compares to Other Basal Insulins for Type 2 Diabetes

Reps will raise questions about whether insulin degludec (Tresiba, etc) is better than other basal insulins (Lantus, etc) for type 2 diabetes.

They're sharing new data that suggest insulin degludec U-100 has a lower risk of symptomatic hypoglycemia than insulin glargine U-100.

But help put this in perspective.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote